Welcome to LookChem.com Sign In | Join Free   Post buying lead  Chemical Tools
Post Buying Lead

Detail of > 76896-80-5

  • MSDS Download
  • CAS Number:
  • 76896-80-5
  • Name:
  • 2,4,7-Undecatrienal,nitrosohydrazone, (2E,4E,7E)-

  • Formula:
  • C11H17N3O
  • Molecular Structure:
  • Synonyms:
  • 2,4,7-Undecatrienal,nitrosohydrazone, (?,E,E,E)-;FR 900190;Triacsin C;WS 1228A;1-hydroxy-3-(2',4',7'-undecatrienylidine)triazene;2,4,7-Undecatrienal nitrosohydrazone;N-(undeca-2,4,7-trienylideneamino)nitrous amide;
  • Molecular Weight:
  • 207.2722
  • Density:
  • 0.941 g/cm3
  • Boiling Point:
  • 320.657 °C at 760 mmHg
  • Flash Point:
  • 147.728 °C
Home > Products > 76896-80-5

Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!

Supplier Location:
China (Mainland)(1)Germany(1)Israel(1)
Business Type:
Importer/Exporter(1)
Certificates:
ISO (0) Production License (0)

Page:1/1   

CAS No. 

76896-80-5 2,4,7-Undecatrienal,nitrosohydrazone, (2E,4E,7E)-

TRIACSIN C
China (Mainland)  
Jia xin zhong yi
  • Tel:86-010-84253186,010-84252066
  • Address:beijing

CAS No. 

76896-80-5 2,4,7-Undecatrienal,nitrosohydrazone, (2E,4E,7E)-

more information,pls contact with us!
Germany  
  • Tel:49-40-8532600
  • Address:Germany

CAS No. 

76896-80-5 2,4,7-Undecatrienal,nitrosohydrazone, (2E,4E,7E)-

Israel   26
  • Tel:972 2 5853953
  • Address:Yatziv 25, POB 47120, Jerusalem 97800 Israel
  • Total:3 Page 1 of 1 1
  • Please post your buying leads,so that our qualified suppliers will soon contact you!
    *Required Fields

    Reference

    cDNA and protein sequences of human Acyl-CoA synthetases and its use for diagnosis, treatment and drug screening for cancers
    All Rights Reserved. cDNA and protein sequences of human Acyl-CoA synthetases and its use for diagnosis, treatment and drug screening for cancers. 76896-80-5 and 922199-48-2 are also occured in this study. Mashima, Tetsuo; Tsuruo, Takashi (Japanese Foundation for Cancer Research; Takeda Pharmaceutical Company Limited, Japan). PCT Int. Appl. WO 2007010628 A1 25 Jan 2007, 167pp. DESIGNATED STATES: W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW; RW: AT, BE, BF, BJ, CF, CG, CH, CI, CM, CY, DE, DK, ES, FI, FR, GA, GB, GR, IE, IS, IT, LU, MC, ML, MR, NE, NL, PT, SE, SN, TD, TG, TR. (Japanese). (World Intellectual Property Organization). CODEN: PIXXD2. APPLICATION: WO 2005-JP13908 22 Jul 2005. DOCUMENT TYPE: Patent CA Section: 3 (Biochemical Genetics) Section cross-reference(s): 7, 13, 14 This invention provides cDNA and protein sequences of human Acyl-CoA synthetases. The Acyl-CoA synthetases inhibitor, triacsin c, can induce apoptosis and repress cell proliferation of human solid cancer caused by mutation in p53 gene. The Acyl-CoA synthetases provided in this invention can be used for diagnosis, treatment and drug screening for cancers. .

    ©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

    [Hangzhou]86-571-85317600,85317603,85317620